Mohammed Milhem
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| 5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors (NCT07404332) | Mohammed Milhem | 2026-02-11 |
| Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab (NCT05363631) | Mohammed Milhem | 2022-09-19 |
| Chlorpromazine and Standard of Care in Glioblastoma (NCT05190315) | Mohammed Milhem | 2022-01-28 |
| High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas (NCT03508726) | Mohammed Milhem | 2019-06-27 |
Track Mohammed Milhem automatically
Every clearance here is in the API, with alerts when new ones post.